Biden administration officials met with suppliers Nov. 27 to discuss how to move forward heading into winter, when RSV tends to increase. They also discussed planning for the second year of the monoclonal antibody drug’s rollout next fall, according to a Nov. 28 White House news release.
The CDC released an additional 77,000 doses of Beyfortus on Nov. 16 to increase access after advising clinicians in late October to reserve the dwindling supplies for those most in need.
“Monday’s meeting follows numerous in-person and virtual meetings to seek ways manufacturers can make more RSV immunizations available for infants,” the news release read. “CDC’s Vaccines for Children program provides vaccines to half of America’s children and senior administration officials will continue to work directly with distributors and manufacturers to make sure the RSV immunization, flu vaccine, and updated COVID-19 vaccine are available.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.